Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics - Zug, Switzerland (ots/PRNewswire) – Alnylam Pharmaceuticals, Inc. (http://www.alnylam.com/) (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma (https://www.medisonpharma.com/) (“Medison”), a global pharma company focused on providing access to highly innovative therapies for patients in international markets, have announced an expansion of their existing partnership to a multi-regional agreement that includes Poland, Czech Republic, Hungary, […]
Die große Online-Datenbank für Presseinformationen in Text, Bild, Audio und Video.Pressemitteilungen und Pressematerial zu sehr vielen verschiedenen Themen. Ein Service von news aktuell aus der dpa-Firmengruppe. Internetseite: www.presseportal.de
Letzte Artikel von Presseportal (Alle anzeigen)